<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://newsletter.glp1studio.com/p/gallup-poll-11-of-us-adults-report</loc><news:news><news:publication><news:name>GLP-1 Studio</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-25T17:00:00+00:00</news:publication_date><news:title>Gallup poll: 11% of US adults report taking GLP-1 drugs</news:title></news:news></url><url><loc>https://newsletter.glp1studio.com/p/semaglutide-kidney-trial-and-other</loc><news:news><news:publication><news:name>GLP-1 Studio</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-25T17:00:00+00:00</news:publication_date><news:title>Semaglutide kidney trial and other diabetes studies, Sept to Oct 2026</news:title></news:news></url></urlset>